Richards Nick, Hassan Mohamed, Saleh Abdul Karim, Dastoor Hormazdiar, Bernieh Bassam, Abouchacra Samra, Al Jabri Omar, Fleischmann Alan, Richards Marie, Marcelli Daniele
Head Office, SEHA Dialysis Service, Abu Dhabi, United Arab Emirates.
Saudi J Kidney Dis Transpl. 2015 Sep;26(5):1028-34. doi: 10.4103/1319-2442.164600.
According to estimates, the dialysis prevalence in Abu Dhabi is around 370 per million population. The annual growth is 12-15% and the dialysis population is likely to double in the next five years. Most patients present to dialysis as an emergency and only 2.7% have an arteriovenous fistula at the first dialysis. The prevalence of chronic kidney disease (CKD) in the Emirate is undefined. A study of the epidemiology of CKD and referral patterns was undertaken. SEHA, the Abu Dhabi Health Service delivery company, has a unified computer system containing all measurements made in its laboratories. This study considered all serum creatinine measurements performed between 1 September 2011 and 31 October 2012 from outpatient departments or emergency rooms. The estimated glomerular filtration rate (eGRF) was calculated using the Modification of Diet in Renal Disease formula (the Schwartz formula was used for children). We identified 331,360 samples from 212,314 individuals. The mean serum creatinine was 61 ± 48 μmol/L in females (59 ± 43 μmol/L in Emiratis, 63 ± 54 μmol/L in expatriates) and 87 ± 69 μmol/L in males (80 ± 59 μmol/L in Emiratis, 92 ± 74 μmol/L in expatriates). Among Emiratis, 4.6% of males and 2.8% of females had an eGFR between CKD 3 and 5. Among expatriates, 4.2% of males and 3.2% of females had an eGFR between CKD 3 and 5. On average, eight months elapsed before a patient with CKD 3, and three months for a patient in CKD 5, to attend the nephrology clinic. This study has defined the prevalence of CKD within Abu Dhabi and demonstrated the need to improve identification and referral of CKD patients. Possible solutions include campaigns to increase public and physician awareness of CKD.
据估计，阿布扎比的透析患病率约为每百万人口370例。年增长率为12%至15%，透析人口在未来五年内可能会翻倍。大多数患者是在紧急情况下开始透析的，首次透析时只有2.7%的患者有动静脉内瘘。阿联酋慢性肾脏病（CKD）的患病率尚不明确。开展了一项关于CKD流行病学和转诊模式的研究。阿布扎比医疗服务提供公司SEHA拥有一个统一的计算机系统，其中包含其实验室进行的所有测量数据。本研究纳入了2011年9月1日至2012年10月31日期间门诊或急诊室进行的所有血清肌酐测量值。使用肾脏病饮食改良公式（儿童使用施瓦茨公式）计算估计肾小球滤过率（eGFR）。我们从212,314名个体中识别出331,360份样本。女性的平均血清肌酐为61±48μmol/L（阿联酋女性为59±43μmol/L，外籍女性为63±54μmol/L），男性为87±69μmol/L（阿联酋男性为80±59μmol/L，外籍男性为92±74μmol/L）。在阿联酋人中，4.6%的男性和2.8%的女性eGFR处于CKD 3至5期。在外籍人员中，4.2%的男性和3.2%的女性eGFR处于CKD 3至5期。CKD 3期患者平均需要八个月，CKD 5期患者平均需要三个月才会前往肾病科就诊。这项研究确定了阿布扎比CKD的患病率，并表明需要改善CKD患者的识别和转诊。可能的解决方案包括开展活动，提高公众和医生对CKD的认识。
